Novo Nordisk Shares Fall as Trump Moves to Cut Price of Weight-Loss Drugs

Core Point - The president indicated that the cost of the weight-loss drug is expected to decrease for Americans following the conclusion of negotiations with Novo Nordisk [1] Group 1 - The negotiations with Novo Nordisk are aimed at reducing the price of the weight-loss drug for American consumers [1]